Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Non Operating Income (2024 - 2025)

Historic Non Operating Income for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $34000.0.

  • Kairos Pharma's Non Operating Income rose 20967.74% to $34000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$160000.0, marking a year-over-year change of. This contributed to the annual value of -$260000.0 for FY2024, which is 16530.61% down from last year.
  • Kairos Pharma's Non Operating Income amounted to $34000.0 in Q2 2025, which was up 20967.74% from $4000.0 recorded in Q1 2025.
  • Over the past 5 years, Kairos Pharma's Non Operating Income peaked at $466000.0 during Q4 2024, and registered a low of -$664000.0 during Q3 2024.